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Abstract
Background: Clinical prediction models (CPMs) predict the risk of health outcomes for individual patients. The
majority of existing CPMs only harness cross-sectional patient information. Incorporating repeated measurements,
such as those stored in electronic health records, into CPMs may provide an opportunity to enhance their
performance. However, the number and complexity of methodological approaches available could make it difficult
for researchers to explore this opportunity. Our objective was to review the literature and summarise existing
approaches for harnessing repeated measurements of predictor variables in CPMs, primarily to make this field more
accessible for applied researchers.
Methods: MEDLINE, Embase and Web of Science were searched for articles reporting the development of a multivariable
CPM for individual-level prediction of future binary or time-to-event outcomes and modelling repeated measurements of at
least one predictor. Information was extracted on the following: the methodology used, its specific aim, reported advantages
and limitations, and software available to apply the method.
Results: The search revealed 217 relevant articles. Seven methodological frameworks were identified: time-dependent
covariate modelling, generalised estimating equations, landmark analysis, two-stage modelling, joint-modelling, trajectory
classification and machine learning. Each of these frameworks satisfies at least one of three aims: to better represent the
predictor-outcome relationship over time, to infer a covariate value at a pre-specified time and to account for the effect of
covariate change.
Conclusions: The applicability of identified methods depends on the motivation for including longitudinal information and
the method’s compatibility with the clinical context and available patient data, for both model development and risk
estimation in practice.
Keywords: Longitudinal data, Clinical risk prediction, Dynamic prediction, Prediction models, Survival analysis, Repeated
observations, Electronic health records, Personalised medicine, Time-dependent covariates, Joint models
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Background
Clinical prediction models (CPMs) aim to predict the
risk of health outcomes such as disease onset, disease
progression or likely outcomes of treatment [1]. Such
predictions are based on available information about an
individual at the time of prediction and can be used to
inform patient care. This could be by offering preventa-
tive interventions to those predicted to be at high risk of
an adverse outcome or relaxing the monitoring of those
predicted to be at low risk. A clinical example of the
former is the QRISK prediction tool currently used in
primary care to estimate a patient’s 10-year risk of
cardiovascular disease (CVD) [2]. UK health guidelines
advise that anyone with an estimated CVD risk of 10%
or higher (from the QRISK model) should be prescribed
a statin to reduce their risk of CVD onset [2, 3].
The majority of current CPMs use patient information
from only a single time point to make predictions and
fail to take advantage of longitudinal medical data, such
as that available in electronic health records (EHRs). It
has been hypothesized that repeated observations pro-
vide a predictive advantage over cross-sectional informa-
tion as they capture change in individual patients over
time and are less sensitive to measurement error [4, 5].
Furthermore, recent empirical reviews comparing longi-
tudinal CPMs to the traditional cross-sectional ones pro-
vide some evidence that the overall predictive accuracy
can be improved by incorporating the longitudinal pa-
tient information [5–9].
While an increasing number of CPMs are being devel-
oped using EHR data, a systematic review showed that
less than 9% of identified CPMs exploited the time-
varying nature of their predictor variables [6]. Therefore,
although methods for longitudinal data analysis are well
established, they appear to be under-utilised in the de-
velopment of CPMs.
To the authors’ knowledge, a broad review of available
methods adopted for harnessing longitudinal data in binary
or time-to-event CPMs has not yet been performed. Binary
and time-to-event outcomes are of primary interest here as
they are the most commonly reported amongst the
prediction-modelling literature [6, 7]. Previous reviews have
been restricted to simpler methods [8], methods most
compatible to a particular clinical application [5, 9–11], or
they have been restricted to the two commonly considered
methods in the field of CPMs (i.e. joint models and landmark
analysis, see Results for method description) [12–14]. The
availability of a broad review could help the development of
longitudinal CPMs and their potential use in practice.
Our primary objective was to review the literature and
provide applied researchers with a comprehensive sum-
mary of existing approaches used for harnessing re-
peated measurements of predictors in CPMs. To address
this objective, we sought to group identified methods
based on their similarity and how they use repeated ob-
servations to enhance prediction, as well as outline their
reported advantages and limitations. Our secondary ob-
jectives were to provide guidance on how to choose an




Within this review, longitudinal information is defined as
repeated measurements through time of predictor vari-
ables. Predictor variables here are defined as measurable
factors that are potentially predictive of health outcomes
of interest. The terms `predictors’ and `covariates’ will
also be used interchangeably for `predictor variables’.
Note that the analytical methods discussed in this review
are sometimes categorised under the term `dynamic pre-
diction’. However, dynamic prediction can cover a broader
range of aims and methods than those of interest here. In
particular, the methods covered in this review are distinct
to those for addressing calibration drift [15] or modelling
disease state transitions [16].
Search strategy
The search strategy in Table 1 was designed to find
peer-reviewed journal articles that described the devel-
opment of a CPM for individual-level prediction of a
binary or time-to-event outcome, and accounted for re-
peated measurements over time of at least one predictor
variable during model development.
The search terms (Table 1) were entered into MED-
LINE (via Ovid), Embase (via Ovid) and Web of Science.
The search was restricted to peer-reviewed journal arti-
cles in English. Further details about any refinements
specific to each database have been reported in Table 2.
Duplicates were removed using automatic deduplication
on both EndNote X8 and Mendeley Desktop.
Inclusion and exclusion criteria
A two-stage screening process was performed prior to
full-text assessment for eligibility. Different sets of inclu-
sion criteria were used to screen titles and abstracts, set
A and set B respectively. Set B was also used for full-text
assessment. Both sets of inclusion criteria are clearly
stated, alongside the rule of inclusion, in Table 3. For an
article to be taken through a stage of the screening
process (or the full-text assessment), it must have satis-
fied the `rule of inclusion’ (e.g. article titles that did not
satisfy either criterion 1 or 2 alongside criterion 3 in set
A were excluded from the review). If it was unclear
whether an article satisfied the inclusion criteria in the
relevant set, it was automatically brought forward to the
next stage (i.e. to abstract screening or full-text
assessment).
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Information extraction
The following information was extracted from relevant
journal articles: the method for modelling longitudinal
predictor variables, the aim of the method, the computer
software used (if stated), the number and type of vari-
ables modelled longitudinally within the CPM, the clin-
ical application and publication year. Publication years
were extracted to provide a graphical overview of
method usage over time. For any methods identified
during the search, reported advantages, challenges and
opportunities for future work regarding their application
in CPMs were also extracted.
Results
Database search
The database search produced 10 615 results, which in-
cluded 6960 unique peer-reviewed journal articles after
Table 1 Search strategy in Ovid format, as entered into MEDLINE and Embase
1 ((repeat* adj1 measure*) OR ``repeatedly-measured" OR (repeat* adj1 observ*) OR ``repeatedly-observed").ti,ab
2 ``time-series" OR ``time-series" OR (``longitudinal" adj2 ``data")).ti,ab
3 ``longitudinal" adj3 (``survival" OR ``binary")) OR ((``longitudinal" OR ``repeat" OR ``discrete") adj2 (``time-to-event" OR (event* adj2 time*)))).ti,ab
4 ((time-depend* OR ``time-varying" OR ``longitudinal") adj1 (coefficient* OR variable* OR covariate* OR marker* OR factor* OR observ* OR
measure* OR biomarker* OR model* OR predictor*)).ti,ab
5 ((predict* adj1 (accurac* OR ``power" OR individual* OR ``future" OR ``time-to-event" OR (event* adj2 time*) OR ``binary")) OR ``predictive ability"
OR ``predictive performance").ti,ab
6 (((``predictive" OR ``prediction" OR ``prognostic") adj1 (tool* OR scor* OR ``algorithm" OR model* OR rule*))).ti,ab
7 ``predict" or ``predicts" or ``prediction" or ``predicting") adj2 (risk* OR ``outcome" OR ``incidence" OR ``time" OR development* OR event* OR
``disease" OR recurrence* OR ``progression" OR ``severity" OR ``achievement" OR ``status" OR ``application")).ti,ab
8 ((``predict" or ``predicts" or ``prediction" or ``predicting") adj3 (``mortality" OR ``survival")).ti,ab
9 (``dynamic prediction" OR ``dynamic predictions" OR ``dynamic prognostic" OR ``dynamic clinical prediction").ti,ab
10 1 OR 2 OR 3 OR 4
11 5 OR 6 OR 7 OR 8
12 10 AND 11
13 12 OR 9
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Table 3 Inclusion criteria used for the title, abstract and full-text
screening
Inclusion criteria set A
(for titles)
Inclusion criteria set B
(for abstracts and full-texts)
1 Development of a CPM. Development of a
multivariable CPM, which
predicts a binary or time-to-
event outcome.
2 Modelling techniques for
longitudinal and survival/
binary data.
CPM accounts for repeated
measurements over time of at
least one predictor variable.
3 Clinical application
described or article
published in a medical or
biometric journal.
CPM has been developed for a
binary or time-to-event out-
come for an individual.
Inclusion
rule
(1 OR 2) AND 3 1 AND 2 AND 3
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the removal of duplicates, book chapters and conference
proceedings. Following title screening, 752 articles
remained in the review. The abstract screening and full-
text assessment for eligibility left 247 and 217 articles re-
spectively. The full screening process and reasons for ex-
clusion have been described in Fig. 1. Additional file 1
lists all the articles included in the review.
Methodological review
The following terminology was identified within the re-
view, which we here define to facilitate the understand-
ing and comparison of methods described below:
landmark time, prediction time, horizon time, observa-
tion window and prediction window (see Fig. 2). Land-
mark time is equivalent to prediction time, which is the
time that an individual’s prognosis is being assessed.
Horizon time is the end of the period that the prediction
applies to. As an example, the QRISK models are devel-
oped to predict 10-year risk of cardiovascular disease,
the horizon time is thus landmark time + 10 years [2].
Observation window refers to the period of time where a
patient’s covariate history can be observed for the pur-
pose of inclusion into the CPM, which is always prior
and up until the landmark/prediction time. Finally, the
Fig. 1 PRISMA flow diagram to illustrate the screening process
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prediction window is the time period between the land-
mark time and horizon time.
From the included studies, three distinct methodo-
logical aims for harnessing repeatedly measured predic-
tors in the development of CPMs were identified. All of
the discovered methods satisfied one or more of these
three methodological aims: (A1) to better represent the
predictor-outcome relationship, (A2) to infer or predict
a covariate value at a pre-specified time or (A3) to ac-
count for the effects of how a predictor changes over
time. It is important to highlight that the content of this
methodological review only covers methods reported in
the identified literature via the database search, and that
other valid approaches may exist but have not yet been
applied in this field of clinical risk prediction.
Methods satisfying A1 tend to utilise repeated observa-
tions to represent a time-constant relationship, or better
represent a time-varying relationship, between a predictor
and the event of interest. Consequently, these methods
often also allow for updated predictions through time. A2
is often pursued to either account for measurement error
or random noise, or to impute missing data when mea-
surements are irregularly-spaced. Methods for A3 are
adopted when it is the behaviour of the covariate that is
considered predictive of the event of interest.
In addition to identifying the three aims, the available
methods were categorised into seven distinct frame-
works: time-dependent covariate modelling (TDCM),
generalised estimating equations (GEE), landmark ana-
lysis (LA), two-stage modelling (TSM), joint-modelling
(JM), trajectory classification (TC) and machine learning
(ML). All identified methods require subject-level longi-
tudinal information on a study population for CPM de-
velopment. The TSM, JM and TC frameworks (as well
as some ML algorithms) can also harness a subject’s re-
peated measurements at the time of prediction. Mean-
while, as stand-alone frameworks, the TDCM, GEE and
LA frameworks only require a subject’s most recent
observations (i.e. a maximum of one measurement for
each predictor) at the time of prediction. Figure 3 pro-
vides an overview of framework adoption over the past
decade, showing that the JM, TSM, LA and ML frame-
works appear to be the most popular. GEE and TC
frameworks are the least adopted frameworks.
Some of the above frameworks have been extended to
harness `functional data’, defined by Li and Luo [17] as
data that ‘provide information about curves, surfaces, or
anything else varying over a continuum’. For our review,
this includes functional data on both a one-dimensional
time domain such as heart rate monitor data or electro-
encephalogram data, and on higher dimensional do-
mains such as magnetic resonance imaging or positron
emission tomography. Any extensions of methods for
functional data will be specified below. Multivariate lon-
gitudinal methods for prediction tailored to functional
data generated in a critical care setting were also out-
lined by Plate et al. in 2019 [11]. The remainder of this
subsection provides a detailed description of each identi-
fied methodological framework in turn. The description
includes how they use longitudinal information, their re-
ported advantages and limitations, and their extensions.
An overview of each framework, their corresponding
available software and example clinical applications is re-
ported in Table 4.
Time-dependent covariate modelling
The most prominent approach before 2009 was to in-
clude time-dependent covariates within a survival model
[5, 18]. We refer to this technique as the TDCM frame-
work, as it can be applied to various adaptations of Cox
regression models. The TDCM framework allows for in-
stantaneous risk estimates to be produced at any time
within the observation window and prediction window
conditional on survival up until that time, whilst harnes-
sing an individual’s most recent observations [5, 19–21].
Conceptually, this approach compares the most recent
Fig. 2 Temporal terminology for harnessing repeated measurements of predictors in clinical prediction models
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covariate values for those still at risk just before each
event time for those who have and have not experienced
an event at that specific time. From there, the hazard
function is updated over time and a time-constant effect
between each covariate and the event of interest is esti-
mated [5]. Therefore, TDCM falls under the first meth-
odological aim (A1) and, as the timing of each event is
required, can only handle time-to-event outcomes.
TDCM provides an advantage over baseline CPMs by
enabling risk estimates to be updated during follow-up
for new individuals, using their most recent covariate
values [22]. Applying baseline CPMs to patient data col-
lected during follow-up would lead to under-estimated
risk predictions and over-estimated survival predictions
[22]. However, TDCM has been heavily criticised
throughout the literature for the following reasons. First,
covariate values are assumed to be measured without
error [5, 21]. Second, repeated covariate values over time
are assumed to remain constant between data collection
points [5, 21]. Third, correlations between and within
subject measurements are not taken into account [21].
Finally, and most importantly, a time-dependent survival
model is unable to predict into the future beyond the
first change in the covariates [21, 23].
To elaborate on this final limitation, the challenge
lies with the requirement of patient covariate values
at the horizon time, as these are unknown for new
individuals in practice. The simplest, and most com-
mon approach, to overcoming this final limitation is
to use last observation carried forward (LOCF) from
landmark time to horizon time [5]. This variation of
TDCM has been employed, for example, to assess the
prognosis of individuals with hepatocellular carcinoma
at any stage of their disease using their most recent
clinical information (Table 4) (103). The magnitude
of the error introduced by the LOCF aspect of pre-
diction for a new individual is usually dependent on
the prediction window size and the stability of pre-
dictor variables over time, with TDCM being argued
as a valid approach for short-term prediction windows
[24].
Extensions of TDCM can account for time-dependent
effects of predictors [25, 26], and aim to minimise the
error caused by the LOCF approach by including time
since measurement as a predictor [27], or including ag-
gregated summaries of covariates [26].
Generalised estimating equations
Similarly to the TDCM framework, the primary meth-
odological aim of generalised estimating equations
(GEE) is to utilise repeated observations from the
same individual to better represent the association be-
tween the predictor variables and the event of inter-
est. However, unlike the TDCM framework, GEE
models account for within and between individual
correlation, can directly harness repeated events per
individual [28, 29], and can model either binary or
survival outcomes. In general, GEE models are most
suitable when the model development data violates
the independence assumption and the model devel-
oper’s primary interest is in the most accurate estima-
tion of the predictor-outcome relationship.
More specifically for clinical risk prediction, GEEs
have been employed to handle repetitions of cross-
sectional patient information through time (both
baseline and outcome information), which will here
be referred to as `cycles’ of patient information [28–
30]. As an example, a patient may experience several
cycles of the same treatment (e.g. chemotherapy) to
treat their condition (e.g. cancer); therefore, multiple
pre-treatment measurements and multiple post-
treatment adverse outcomes per patient could be
utilised to develop a CPM for predicting adverse out-
comes from chemotherapy [28–30].
Fig. 3 Number of publications per year for each framework (n = 182), excluding methods in comparative reviews
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Traditional logistic regression would not be able to
utilise such patient information as it violates the inde-
pendence assumption, that each observation (for an indi-
vidual) is independent of other observations. An
alternative model to handle cycles of patient information
is a beta-geometric model that has been used to predict
natural conception for women, after multiple cycles of a
relevant procedure [31].
Table 4 Methodological frameworks available to enhance clinical prediction models using longitudinal information
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Abbreviations: LOCF last observation carried forward, ME mixed effect, SVM support vector machine, MCMC Markov chain Monte Carlo, EHR electronic
health record, JLCM joint latent class model
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Landmark analysis
The landmark analysis (LA) framework derives separate
cross-sectional CPMs for those still at risk at various
landmark time points during follow-up. The flexibility in
choice of model used to develop the CPM at each land-
mark time point allows for both binary and survival out-
comes to be modelled under this framework. The
methodological goal of this framework, which is similar
to TDCM and based on conditional survival modelling
[32], is to acknowledge that those who have survived for
longer are more likely to have a better prognosis than
those who have not [32]. Unlike TDCM, LA can use past
or current information from new individuals to make
predictions about their future [33]. The CPMs developed
at each landmark time post-baseline can take into ac-
count the covariate history until the landmark time
point, but a patient’s most recent observation is
employed in time-fixed CPMs [28]. For example, the LA
framework has been adopted with binary time-
dependent covariates to predict relapse or death for
those in remission from leukaemia after a bone marrow
transplant [34], as shown in Table 4. The CPMs devel-
oped post-baseline acknowledged whether the patient
had or hadn’t experienced complications since their sur-
gery [34]. LA as a stand-alone framework utilises longi-
tudinal information to account for change in an at-risk
population when specifying the predictor-outcome rela-
tionship, and therefore satisfies the first methodological
aim (A1).
For CPM development, it is common to merge all risk-
sets (i.e. data required to develop a CPM at each landmark
time) into a stacked dataset and fit just one model to the
available data, including landmark time as an independent
variable. This is often referred to as the `super landmark
model’ [34, 35]. Correlations between the within-subject
observations can be accounted for using GEEs [35], and
non-parametric time-varying coefficients can be modelled
over landmark time points [36, 37].
The LA framework is a simple way to update risk pre-
dictions over time, without imposing too many assump-
tions on the available information, and it can handle a
large number of time-dependent covariates [36–39]. Its
simplicity may also lead it to being more robust to mis-
use in practice as it is straightforward to implement and
interpret by the end-users [36, 39].
However, it appears that there is no general guidance
on the choice of landmark times as they vary with each
application. Examples include using quantiles of event
times to capture the changes in the at-risk population
[35] or using different follow-up appointment times in
clinical practice [34]. Implementation can also be chal-
lenging for left-censored information, and routinely col-
lected data with no defined baseline time-point [37].
CPMs developed in routinely collected data have used
age as the landmark time to overcome this barrier [38].
Furthermore, the LA framework carries the same limita-
tions as any conditional survival model, which is the re-
quirement of a large dataset, complete with long-term
follow-up covariate and event information for each of
the landmark time points [32].
Mixed-effects or auto-regressive time series models
can also be used to capture a subject’s covariate trajec-
tory and predict the value of a covariate at each land-
mark time point [23, 34, 37, 38, 40]. Various survival
models have also been applied to account for competing
risks [41], recurrent events [36] and cure fraction models
[42]. Thus, variations of the LA framework may fall
under the second and third methodological aim (A2 and
A3) if combined with the two-stage framework (dis-
cussed below).
Two-stage modelling
The two-stage modelling (TSM) framework considers the
modelling processes for repeated measurements (longitu-
dinal model) and outcome prediction (survival or binary-
outcome model) separately. A parameter estimate from
the longitudinal model is included as a fixed-time covari-
ate in the survival (or binary-outcome) model. TSM as a
stand-alone framework is often employed to satisfy the
second or third methodological aim, depending on
whether it is the behaviour of the predictor which is
placed into the second model (A3), or the predicted value
of a covariate at a pre-specified time (A2).
The key advantage of this approach is that it is compu-
tationally efficient, especially compared to joint modelling
[21, 43]. However the two stages are performed separately
and acknowledgment of any error in the estimation
process for the longitudinal model is not carried forward
into the outcome prediction model [5]. Therefore, any
resulting predictions could appear too precise [5].
In the TSM framework, many different statistical
models could be applied at each of the two stages in the
CPM development process. The simplest and most com-
mon approaches applied for the first stage are to aggre-
gate the repeated observations into a summary statistic
or to fit a mixed-effect model (described below). Other
examples include functional principal components and
time series; these methods are described in Additional
file 2. Examples of the survival or binary outcome
models include Cox proportional hazards [44], logistic
regression [45, 46] and partly conditional models [43].
Aggregated data In the aggregated data approach, all
available covariate information up until prediction time
is aggregated into a summary statistic. Examples include
the use of the cumulative mean, rate of change, standard
deviation or variance, coefficient of variation or the
minimum/maximum value of available measurements
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for each individual [2, 5, 8, 47–49]. The most common
statistic for models developed on EHR data was the ex-
treme (min/max) value of a predictor within a pre-
specified observation window [50].
This approach attempts to minimise the effect of
measurement error on individual risk predictions by
summarising over the longitudinal trajectory. The clear
advantages of this approach are the simplicity, lack of
computational demand, reduced sensitivity to noisy data
and ability to handle multiple repeatedly-measured pre-
dictors [9]. However, the unbiased estimates of the
mean, standard deviation and variance assume no under-
lying trend, bias, or variability change in the process,
which is unrealistic for most clinical data [5].
Mixed-effect models Mixed-effects (ME) models can
also be referred to as random-effects, hierarchical or
multi-level models. Their name derives from the idea
that population-level information is used to support and
enhance power for subject-level inference where individ-
ual measurements may be minimal. Population-level in-
formation is captured in fixed effects, and subject-level
variations from the population are captured in random
effects [9, 51]. These include linear mixed models [5, 51,
52] and generalised linear mixed models [9, 13, 40, 53].
ME models can be used to represent the longitudinal
trajectory of a predictor variable over time, and may or
may not include additional predictors for the longitu-
dinal predictor outcome. The random effects from this
model, which reflect individual-level rate of change or
an inferred value of a predictor variable (at a pre-
specified time), could be included into a cross-sectional
CPM [46]. For example, a linear mixed model (LMM)
has been employed to represent a patient’s aneurysm sac
diameter change over time [44]. Using this LMM, each
new patient’s aneurysm sac diameter and its rate of
growth can be estimated at the landmark time (using
their previous measurements). These values were then
used as predictors in a Cox survival model to estimate
their risk of an adverse event [44]. This clinical example
also explores LA and TSM combined (Table 4) [44].
Although ME models are extremely flexible, challenges
arise with correctly specifying a parametric trend over
time and how to represent the individual rate of change
in the final CPM. Linear models, quadratic growth
curves [8, 52], fractional polynomials [44] and cubic
splines [9, 13, 53] can be used to model the trend over
time. Most CPM developers have adopted trends from
previous literature in their specific field, but an appropri-
ate model could also be found using data–driven tech-
niques like the multiple fractional polynomial algorithm
[44]. ME models can be extended to have t-distributed
residuals with continuous outcomes to better handle
outlier observations, and within-person correlations for
the repeated measurements [54, 55]. They can also be
extended to account for sub-groups within a population
using latent class methods [56].
Joint modelling
The joint-modelling (JM) framework addresses the limi-
tations of the TSM framework by simultaneously esti-
mating the longitudinal sub-model and the survival or
binary outcome sub-model [13, 51, 52]. The term “joint
model” more broadly refers to any number of statistical
models estimated jointly, but here the literature focussed
on jointly modelling a longitudinal model and a survival
or binary outcome model. Similar to the TSM frame-
work, a ME model was often employed for the covariate
trajectory and a Cox proportional hazards model for a
time-to-event outcome [57]. However, variations of the
event prediction sub-model exist in the CPM literature
such as binary event models [52, 58–61], parametric sur-
vival models [9], models for discrete-time data [9, 62,
63], models for competing risks [64], generalised linear
models [58], and models for left-truncated data [65, 66].
Furthermore, the ME models could be for different types
of data (e.g. functional data) [66, 67], modelling nonlin-
ear functions [68], modelling nonparametric functions
[69, 70] or linear quantile mixed models [71] depending
on the clinical context.
Under all JM frameworks, the various sub-models typ-
ically involve shared random effects, or latent variables,
whether they are continuous or discrete [5, 9]. For the
purposes of clinical risk prediction, three different
frameworks have been described: shared random effects
(SRE) joint models, joint latent class models (JLCM) and
joint frailty models for recurrent events (JFM). A clinical
example of where a SRE joint model has been employed
to predict prostate cancer recurrence has been
highlighted in Table 4. Detailed descriptions of these
sub-categories and their differences can be found in
Additional file 2.
One challenge of using random effects in CPMs is esti-
mating the risk of a future event for a new subject, as
their random effects are unknown. To resolve this, ran-
dom effects can be sampled from their posterior predict-
ive distribution, which is based on the population-level
distribution of random effects from the fitted joint
model, the new subject’s covariate values until the time
of prediction, and conditional on the subject still being
at risk at the time of prediction [72, 73].
A more popular choice is to employ the Monte Carlo
simulation approach as it takes into account the uncer-
tainty around the survival or event probability estimate
[57, 72, 73]. Monte Carlo simulation is, conceptually, a
procedure that repeatedly samples parameter estimates
and random effects based on their estimated posterior
distributions from the fitted joint model [72, 73]. A new
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individual’s random effects can be simulated from their
posterior predictive distribution, as stated above [72, 73].
Repeatedly sampling from the posterior distributions
allows for an empirical distribution around the esti-
mated survival or event probability [73]. Monte Carlo
simulation has been employed independently of the
model estimation process and is reported to be com-
putationally efficient in contrast to the joint model
specification [74, 75].
Trajectory classification
Mixed-effect (ME) models have also been employed to
classify longitudinal trajectories for binary events or cat-
egories; these methods have been grouped under the tra-
jectory classification framework for this review [52, 76,
77]. The methods can alternatively be referred to as
“longitudinal linear discriminant analysis” or “pattern
mixture models” depending on their estimation and clas-
sification process.
In the TC framework for the prediction of binary
events, the binary outcome value of 0 or 1 is seen as a
latent class variable in the mixed-effect model. That is,
the outcome variable interacts with all the predictors
within the mixed-effects model (both fixed and random),
which specifies the longitudinal trajectories. For CPM
development, events are observed and so the parameters
can be estimated, which is like modelling the event and
non-event subjects separately. In practice, when the out-
come is unknown, separate distributions of the longitu-
dinal predictor values can be estimated based on the
event and non-event ME model parameters, as well as
the new subject’s observed longitudinal values [78–80].
Both of these distributions can then be used to produce
a discrimination score, which can later be used to clas-
sify the subject or to produce a posterior probability that
the subject will experience the event [78–80].
A subject’s risk or discriminant score can also be re-
estimated when new information becomes available.
Therefore, this framework satisfies both the first and
third methodological aim (A1 and A3). To extend this
approach to predict time-to-event outcomes, covariate
trajectories may be classified into categories that can
then be used as a predictor within a survival model. This
extension can be performed under the two-stage model-
ling or joint-modelling framework, the latter approach is
referred to as the joint latent class model in Additional
file 2. The TC framework has also been extended to in-
corporate additional models to account for repeated bin-
ary events over time, and for informative processes [76].
Machine learning
The definition of the term machine learning can often
be ambiguous as it covers a broad range of data-driven
algorithms in the fields of statistics and computer
science. For the purpose of prediction, ML algorithms
extend from regression-based models (such as logistic
regression) to more complex mathematical modelling
(such as neural networks). Although methods identified
under the field of machine learning are not independent
of regression-based techniques described elsewhere,
what distinguishes them is their algorithmic design.
In the longitudinal CPM literature, the terms machine
learning, data mining and statistical learning have all
been used to refer to the following algorithms: regu-
larised logistic regression (RLR), elastic net (EN), ran-
dom forests, gradient boosting, support vector machines
(SVM), artificial neural networks, and naïve Bayes (NB).
Additional algorithms have been categorised under
`matching’ algorithms for how they use repeated mea-
surements for binary classification, where the conceptual
interpretation is similar to that of the TC framework,
please see Additional file 2 for further information. The
majority of reported machine learning algorithms were
employed to classify data for binary outcomes, with very
limited attention on time-to-event outcomes [81–83].
Some of the algorithms stated above have been used in
a TSM framework alongside other methods to capture
the longitudinal covariate information, such as aggrega-
tion into summary statistics (RLR, EN, NB) [84–86],
autoregressive time-series modelling (SVM) [87], Gauss-
ian processes (SVM) [88] and temporal extraction [89].
The discussed methods are also often employed amongst
an algorithm which performs variable selection, CPM
development and performance assessment (internal val-
idation) simultaneously [84].
The following subsections will provide a summary of
the most common algorithms (temporal extraction, ran-
dom forests, support vector machines, and artificial
neural networks), and how they have been reported to
incorporate longitudinal information in clinical risk pre-
diction. All of the methods satisfy the third methodo-
logical aim (A3) and can account for the effect of
covariate change on the event of interest.
Temporal extraction Temporal extraction can be used
to define different change types in repeated observation
data such as ‘trends, statuses, and other complex time-
related attributes’ [89]. The temporal patterns over time
can correspond to 13 different temporal operators: BE-
FORE, OVERLAPS, MEETS, STARTS, DURING, and
their inverse relations, as well as EQUALS [89]. A sim-
pler version of this technique only consists of increasing,
decreasing or stationary temporal processes [89]. Varia-
tions of this conceptual idea exist in the machine learn-
ing literature such as time interval related patterns [90,
91], and sequential pattern mining [83]. These algo-
rithms are usually embedded into an algorithmic frame-
work which aims to match patterns over time in a
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current patient to historical patient information and
infer the probability of the outcome of interest [90, 92].
Random forests Random forests are composed of a set
of low-correlated decision trees developed upon subsets
of data generated via bootstrap sampling [84, 93, 94]. A
single decision tree can incorporate nonlinear relation-
ships and interactions of classifications with a simple
representation of the data [85]. Both random forests and
gradient boosting are reported to be advantageous when
a CPM requires a large number of predictors [84]. Gra-
dient boosting is an extension of the random forests that
iteratively generates a sequence of decision trees based
on the misclassification of a previous decision tree [95].
Although random forests have been used with longitu-
dinal data, it is unclear whether any dependence on time
or the ordering of measurements has been acknowledged
as it has recently been described as a time-independent
method [6].
Support vector machines Support vector machines
(SVM) aim to maximise the distance between events and
non-events in a high-dimensional space. SVMs explicitly
divide the two domains with a linear or non-linear func-
tion, often estimated using a Kernel function [94, 96].
SVMs are less sensitive to outliers than standard logistic
regression yet are more computationally intensive as they
can harness high-dimensional covariate information [97].
While this approach has typically been combined (in a
TSM framework) with aggregated data and time-series
modelling techniques [87, 96, 97], SVMs have recently
been employed as a one-stage approach for CPM devel-
opment to harness repeated measurements in an obser-
vation window from EHR data [94]. It is thus implied
that SVM can handle the longitudinal nature of pre-
dictor variables. However, time-dependency may have
still been ignored as it has been reported that SVMs ag-
gregate longitudinal information and ignore temporal re-
lationships [98].
Artificial neural networks Artificial neural networks
(ANNs) are a complex mathematical model designed to
replicate the decision making process of the human
brain. However, unlike the tree-based algorithms de-
scribed above, the network is designed inside a black
box, also known as the hidden layers [85]. ANNs are
specifically able to process nonlinear relationships
amongst dependent and independent variables whose re-
lationships are complex, multidimensional and inter-
active [85].
Artificial neural networks may be able to respect the
structure of longitudinal data, yet this is unclear
amongst the literature. Descriptions of the hierarchical
extension of ANNs explicitly state that time-dependent
covariates can be incorporated into the network, al-
though no explicit applications are suggested [82, 99].
Recurrent neural networks (RNN) are extensions of
ANNs that have the ability to remember historical re-
sults, establish relationships across repeated measure-
ments and acknowledge patterns over time [98, 100].
Unlike articles discussing other ML techniques, articles
using RNNs have been explicit about the method’s abil-
ity to harness high-dimensional data and tackle multi-
variate time-series problems for the prediction of a
binary outcome [99, 101]. Clinically, RNNs were adopted
to predict heart failure based on EHR data in 2018 [98],
see Table 4.
Discussion
This methodological review has identified three ways in
which available methods can utilise longitudinal infor-
mation to enhance the performance of CPMs: (A1) to
better represent the predictor-outcome relationship;
(A2) to infer a covariate value at a pre-specified time
and (A3) to account for the effects of predictor change
over time. All identified methods have been categorised
into seven methodological frameworks which use longi-
tudinal information in different ways: time-dependent
covariate modelling; generalised estimating equations;
landmark analysis; two-stage modelling; joint-modelling;
trajectory classification and machine learning. Four of
these frameworks can harness subject-level repeated
measurements at the time of prediction for a new indi-
vidual, as well as subject-level longitudinal information
on a study population for CPM development.
Recent reviews of available methods for modelling re-
peatedly measured predictor variables in the develop-
ment of CPMs have focussed on evaluating their
predictive advantage over cross-sectional CPMs [5, 8–
12, 14, 21, 102–106]. The range of compared methods
varies across reviews, although joint models are typically
compared with other methods. The choice of reviewed
methods has often been determined by the specific
methodological problem, such as modelling a single lon-
gitudinal predictor [5, 8, 12, 21], modelling multiple ir-
regularly measured predictor variables prior to a fixed
landmark time [9, 10], modelling multivariate longitu-
dinal data in a critical care setting [11] or handling large
datasets with small numbers of events [9]. Other reviews
have been designed for comparing a newly proposed
method with other available methods [21] or comparing
more complex approaches with simpler methods [105,
106]. Finally, some reviews focus solely on the compari-
son of the LA and JM frameworks, which are the most
popular approaches [12, 14, 102, 104].
Problematically, previous reviews and studies often
refer to methods using different names. For example,
TDCM (with a Cox proportional hazards model) has
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been reported as the ‘last observation carried forward’
approach for the way it handles repeated measurements
at the time of prediction [5]. However, this is distinct
from the ‘most recent observation’ approach discussed
in another review, which refers to the application of a
baseline CPM in EHR data [9]. Similarly, ‘ordinary re-
gression calibration’ and ‘risk-set regression calibration’
methods have been defined as a sub-category of ME
models as they have different assumptions for the ran-
dom effects, yet these terms are not used elsewhere [5].
Therefore, we hope that this review will create a prac-
tical guide for researchers wishing to apply these
methods, by providing a unified summary of the
literature.
Welten et al. were the first reviewers to provide a set
of available methods to address the methodological chal-
lenge and the practical implications of modelling re-
peated measurements for individual-level prediction [8].
However, the review focused on simple approaches (in
the TSM framework), arguing that random-effects
models are not appropriate for individual risk prediction
in practice [8]. Nonetheless, it has now been argued that
a new patient’s random effects can be estimated through
Monte Carlo simulation [72, 73]. Plate et al. also pro-
posed a framework to facilitate the understanding and
uptake of a variety of multivariate longitudinal methods
for prediction in critical care in 2019 [11]. Despite the
authors advocating the framework to be more widely ap-
plicable to EHR-style data, the proposed framework was
specified prior to the systematic database search,
whereas the structure of this review’s output has been
completely derived from the identified literature.
As the scope of the current methodological review was
not restricted to a particular clinical application or a par-
ticular set of methods, a key strength of this study is its
ability to provide a broader overview of available meth-
odology, directly compare how methods use longitudinal
information, and highlight some key considerations for
applied researchers when choosing an appropriate
method. These key considerations include, but are not
restricted to, the type and amount of information avail-
able at the time of prediction (including the number and
type of longitudinal predictors), how the CPM can bene-
fit from the longitudinal information and what is known
a priori to model development (i.e. imposed model
assumptions).
During this review, considerations for future methodo-
logical research were also identified. The following as-
pects of CPM development were often overlooked
within the current literature: sample size requirements,
the handling of missing or irregularly-spaced data, ef-
fectively summarising longitudinal information, model
validation (and avoiding statistical overfitting) and fi-
nally, how to quantify the improvement in predictive
accuracy when incorporating repeated measurements.
To elaborate, irregularly spaced measurements cannot
be directly modelled using some methods, and so re-
quire additional imputation methods. Potential algo-
rithms are emerging to choose the best way to
summarise longitudinal trajectories in joint models
[107], but there is limited discussion elsewhere around
variable selection in a longitudinal context. Model valid-
ation techniques remain similar to those for cross-
sectional CPMs where applicable, and the quantification
of predictive improvement is often performed using dif-
ferences in C-index which lacks clinical interpretability
[108]. We recommend future research in each of these
areas.
The limitations of our study should be kept in mind
when interpreting its results. First, the systematic search
employed to identify available methodology was de-
signed using free-text. The evolving nature of this re-
search space has resulted in a lack of uniformity in
language when referring to repeated measurements of
predictor variables and dynamic prediction amongst the
literature. Second, the screening was performed by one
author (LB) which may have introduced subjectivity and
bias into the screening process. Third, while aggregate
details of available software are provided in Table 4, the
frequency and the level of detail of software reporting in
the identified literature were not assessed.
The first limitation may have resulted in the system-
atic search missing some methods. To minimise this
risk, the search in Table 1 was designed to cover all
methodological purposes of longitudinal data for clinical
risk prediction, including prediction of population-level
change, the identification of predictors and methods to
address calibration drift. Furthermore, an initial title
screening with a much broader search strategy was per-
formed to identify further relevant articles from which
key words and terminology could be extracted. To re-
duce the risk of subjectivity as a result of the second
limitation, the reviewer remained cautious about articles
where it was unclear whether they fit the inclusion cri-
teria and carried them forward to the next round of
screening. Despite a general lack of detail in the litera-
ture in the reporting of available software for discussed
methods, all reported available software has been in-
cluded in Table 4. Such information will be useful for
the implementation of identified methods and can pro-
vide an indication of where software may not have been
well-reported.
Having compared how methods use longitudinal infor-
mation, summarised their reported advantages and dis-
advantages and grouped them based on methodological
approach, we hope to facilitate the understanding of a
broad and complex research domain. The findings from
this review consolidate the message from previous
Bull et al. Diagnostic and Prognostic Research             (2020) 4:9 Page 12 of 16
reviews, that there is no straight-forward approach to
developing a longitudinal CPM. However, to reiterate,
the choice of methods is substantially reduced by the
following considerations: the type and amount of infor-
mation available at the time of prediction (including the
number and type of longitudinal predictors), how the
CPM can benefit from the longitudinal information and
the validity of any assumptions for a specific application.
Conclusions
We have grouped methods available for incorporating re-
peatedly measured predictor variables into the develop-
ment of a CPM, identified their methodological aims and
discussed their reported advantages and limitations. In
addition, amongst the literature we found some key con-
siderations for CPM development and identified oppor-
tunities for further methodological research. Most
importantly, however, our review has identified seven
methodological frameworks which offer a wide range of
ways in which longitudinal information can enhance
CPMs by improving the representation of a predictor-
outcome relationship, updating predictions during follow-
up, inferring covariate values, or accounting for the effect
of how a predictor variable changes over time.
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